Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

Most Damaging Clinical Trial Failure: AstraZeneca's MYSTIC
BioPharma Dive
Mon, 12/4/17 - 09:42 pm
Tags:
clinical trials, AstraZeneca, Mystic, Imfinzi, non-small cell lung cancer
AstraZeneca teams with China-owned fund to launch a new biopharma drug development company
Endpoints
Mon, 11/27/17 - 10:13 am
Tags:
AstraZeneca, China, Dizal Pharmaceutical
3 Companies Competing to Gain Lead in Ovarian Cancer Market
Yahoo/Zacks.com
Sat, 11/25/17 - 12:35 pm
Tags:
ovarian cancer, AstraZeneca, Merck, Lynparza, Rubraca, Clovis Oncology, Zejula, Tesaro
Nektar (NKTR) Stock Up More than 300% This Year: Here's Why
Yahoo/Zacks.com
Sat, 11/25/17 - 12:29 pm
Tags:
Nektar, AstraZeneca, Movantik, Onzeald, UCB Pharma, Cimzia, Amgen, Neulasta
J&J, Lilly and AZ diabetes medications get another helping of real-world heart benefits
Fierce Pharma
Fri, 11/24/17 - 09:23 am
Tags:
JNJ, Eli Lilly, AstraZeneca, Boehringer Ingelheim, diabetes, Invokana, Farxiga, Jardiance
AstraZeneca touts Tagrisso's CNS benefit
BioPharma Dive
Tue, 11/21/17 - 09:45 am
Tags:
Tagrisso, AstraZeneca, non-small cell lung cancer, CNS metastases
GlaxoSmithKline's Nucala, buoyed by its medical organization, ready to 'fiercely compete' with AstraZeneca
Fierce Pharma
Mon, 11/20/17 - 11:12 am
Tags:
GSK, Nucala, AstraZeneca, Fasenra, eosinophilic asthma, asthma
Cancer Space Update: Label Expansion for Three Major Drugs
Yahoo/Zacks.com
Fri, 11/17/17 - 11:45 am
Tags:
cancer, labeling, AstraZeneca, Faslodex, Pfizer, Sutent, kidney cancer, Roche, Gazyva, follicular lymphoma
AstraZeneca's Faslodex Gets FDA Nod for Use With Verzenio
Yahoo/Zacks.com
Thu, 11/16/17 - 11:13 am
Tags:
AstraZeneca, Faslodex, FDA, breast cancer, Verzenio, Eli Lilly
AstraZeneca, Merck, Clovis and Tesaro, all vying for share, may all win on faster PARP growth
Fierce Pharma
Wed, 11/15/17 - 08:51 pm
Tags:
AstraZeneca, Merck, Clovis Oncology, Tesaro, PARP inhibitors, ovarian cancer, Zejula, Rubraca, Lynparza
AstraZeneca’s respiratory group scores FDA OK for a blockbuster severe asthma drug
Endpoints
Wed, 11/15/17 - 08:38 am
Tags:
AstraZeneca, FDA, severe asthma
Can AstraZeneca afford its fervent commitment to paying a high dividend?
Fierce Pharma
Fri, 11/10/17 - 10:19 pm
Tags:
AstraZeneca, dividends
AstraZeneca executives try to shift I-O focus with China, Brilinta wins
Fierce Pharma
Fri, 11/10/17 - 09:35 am
Tags:
AstraZeneca, immuno-oncology, China, Brilinta
AstraZeneca Stock Gains as Crestor Sales Decline Slows
TheStreet.com
Thu, 11/9/17 - 05:59 pm
Tags:
AstraZeneca, earnings, Crestor
AstraZeneca inks a cardio drug development pact with mRNA specialist Moderna
Endpoints
Wed, 11/1/17 - 09:53 am
Tags:
AstraZeneca, drug development, MRNA, Moderna Therapeutics
AstraZeneca asthma drug tralokinumab disappoints again
Yahoo/Reuters
Wed, 11/1/17 - 09:37 am
Tags:
AstraZeneca, tralokinumab, severe asthma
AstraZeneca wins US approval for lymphoma drug
Yahoo/AP
Tue, 10/31/17 - 09:24 pm
Tags:
AstraZeneca, FDA, Calquence, mantle cell lymphoma
AstraZeneca plans new pivotal lung cancer trial with Incyte
Yahoo/Reuters
Tue, 10/31/17 - 10:04 am
Tags:
AstraZeneca, Incyte, clinical trials, Imfinzi, epacadostat, lung cancer
AstraZeneca hands Mereo rights to lung drug
BioPharma Dive
Mon, 10/30/17 - 11:23 pm
Tags:
AstraZeneca, Mereo BioPharma, AZD9668
What to expect from the rest of pharma's earnings
BioPharma Dive
Mon, 10/30/17 - 09:52 am
Tags:
earnings, Pfizer, Allergan, Novo Nordisk, Sanofi, AstraZeneca

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.